38 related articles for article (PubMed ID: 9548755)
1. Anticancer Activity of Ω-6 Fatty Acids through Increased 4-HNE in Breast Cancer Cells.
Bose C; Hindle A; Lee J; Kopel J; Tonk S; Palade PT; Singhal SS; Awasthi S; Singh SP
Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944997
[TBL] [Abstract][Full Text] [Related]
2. Haploinsufficiency Interactions between RALBP1 and p53 in ERBB2 and PyVT Models of Mouse Mammary Carcinogenesis.
Singh SP; Lee J; Bose C; Li H; Yuan YC; Hindle A; Singhal SS; Kopel J; Palade PT; Jones C; Rahman RL; Awasthi S
Cancers (Basel); 2021 Jul; 13(13):. PubMed ID: 34283045
[TBL] [Abstract][Full Text] [Related]
3. Haploinsufficiency Interactions of RALBP1 and TP53 in Carcinogenesis.
Awasthi S
Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33445456
[TBL] [Abstract][Full Text] [Related]
4. Rlip Depletion Suppresses Growth of Breast Cancer.
Bose C; Yadav S; Singhal SS; Singhal J; Hindle A; Lee J; Cheedella NKS; Rehman S; Rahman RL; Jones C; Darden M; Palade PT; Berz D; Singh SP; Awasthi S
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32498332
[TBL] [Abstract][Full Text] [Related]
5. 2'-Hydroxyflavanone effectively targets RLIP76-mediated drug transport and regulates critical signaling networks in breast cancer.
Nagaprashantha LD; Singhal J; Li H; Warden C; Liu X; Horne D; Awasthi S; Salgia R; Singhal SS
Oncotarget; 2018 Apr; 9(26):18053-18068. PubMed ID: 29719590
[TBL] [Abstract][Full Text] [Related]
6. Rlip depletion prevents spontaneous neoplasia in TP53 null mice.
Awasthi S; Tompkins J; Singhal J; Riggs AD; Yadav S; Wu X; Singh S; Warden C; Liu Z; Wang J; Slavin TP; Weitzel JN; Yuan YC; Awasthi M; Srivastava SK; Awasthi YC; Singhal SS
Proc Natl Acad Sci U S A; 2018 Apr; 115(15):3918-3923. PubMed ID: 29572430
[TBL] [Abstract][Full Text] [Related]
7. Targeting p53-null neuroblastomas through RLIP76.
Singhal J; Yadav S; Nagaprashantha LD; Vatsyayan R; Singhal SS; Awasthi S
Cancer Prev Res (Phila); 2011 Jun; 4(6):879-89. PubMed ID: 21411502
[TBL] [Abstract][Full Text] [Related]
8. RLIP76: a versatile transporter and an emerging target for cancer therapy.
Vatsyayan R; Lelsani PC; Awasthi S; Singhal SS
Biochem Pharmacol; 2010 Jun; 79(12):1699-705. PubMed ID: 20097178
[TBL] [Abstract][Full Text] [Related]
9. Rlip76 transports sunitinib and sorafenib and mediates drug resistance in kidney cancer.
Singhal SS; Sehrawat A; Sahu M; Singhal P; Vatsyayan R; Rao Lelsani PC; Yadav S; Awasthi S
Int J Cancer; 2010 Mar; 126(6):1327-38. PubMed ID: 19626587
[TBL] [Abstract][Full Text] [Related]
10. Role of RLIP76 in doxorubicin resistance in lung cancer.
Vatsyayan R; Chaudhary P; Lelsani PC; Singhal P; Awasthi YC; Awasthi S; Singhal SS
Int J Oncol; 2009 Jun; 34(6):1505-11. PubMed ID: 19424567
[TBL] [Abstract][Full Text] [Related]
11. RLIP76: a target for kidney cancer therapy.
Singhal SS; Singhal J; Yadav S; Sahu M; Awasthi YC; Awasthi S
Cancer Res; 2009 May; 69(10):4244-51. PubMed ID: 19417134
[TBL] [Abstract][Full Text] [Related]
12. Functional reconstitution of RLIP76 catalyzing ATP-dependent transport of glutathione-conjugates.
Singhal SS; Sehrawat A; Mehta A; Sahu M; Awasthi S
Int J Oncol; 2009 Jan; 34(1):191-9. PubMed ID: 19082490
[TBL] [Abstract][Full Text] [Related]
13. RLIP76: A novel glutathione-conjugate and multi-drug transporter.
Singhal SS; Yadav S; Roth C; Singhal J
Biochem Pharmacol; 2009 Mar; 77(5):761-9. PubMed ID: 18983828
[TBL] [Abstract][Full Text] [Related]
14. RLIP76 and Cancer.
Awasthi S; Singhal SS; Awasthi YC; Martin B; Woo JH; Cunningham CC; Frankel AE
Clin Cancer Res; 2008 Jul; 14(14):4372-7. PubMed ID: 18628450
[TBL] [Abstract][Full Text] [Related]
15. Hsf-1 and POB1 induce drug sensitivity and apoptosis by inhibiting Ralbp1.
Singhal SS; Yadav S; Drake K; Singhal J; Awasthi S
J Biol Chem; 2008 Jul; 283(28):19714-29. PubMed ID: 18474607
[TBL] [Abstract][Full Text] [Related]
16. Mass spectroscopic phosphoprotein mapping of Ral binding protein 1 (RalBP1/Rip1/RLIP76).
Herlevsen MC; Theodorescu D
Biochem Biophys Res Commun; 2007 Oct; 362(1):56-62. PubMed ID: 17706599
[TBL] [Abstract][Full Text] [Related]
17. ATP-Dependent human erythrocyte glutathione-conjugate transporter. II. Functional reconstitution of transport activity.
Awasthi S; Singhal SS; Pikula S; Piper JT; Srivastava SK; Torman RT; Bandorowicz-Pikula J; Lin JT; Singh SV; Zimniak P; Awasthi YC
Biochemistry; 1998 Apr; 37(15):5239-48. PubMed ID: 9548755
[TBL] [Abstract][Full Text] [Related]
18. ATP-Dependent colchicine transport by human erythrocyte glutathione conjugate transporter.
Awasthi S; Singhal SS; Pandya U; Gopal S; Zimniak P; Singh SV; Awasthi YC
Toxicol Appl Pharmacol; 1999 Mar; 155(3):215-26. PubMed ID: 10079207
[TBL] [Abstract][Full Text] [Related]
19. ATP-Dependent human erythrocyte glutathione-conjugate transporter. I. Purification, photoaffinity labeling, and kinetic characteristics of ATPase activity.
Awasthi S; Singhal SS; Srivastava SK; Torman RT; Zimniak P; Bandorowicz-Pikula J; Singh SV; Piper JT; Awasthi YC; Pikula S
Biochemistry; 1998 Apr; 37(15):5231-8. PubMed ID: 9548754
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
